At Cerustar, we utilize leading-edge life sciences technology to provide patients with new forms of value that “enriches their lives.”

Nowadays, “objects” are not the only means of treating the living body. Recent research has shown that “cells” are also a viable option and they are now being put to practical use.

At Cerustar, we are conducting joint research with the Singaporean Agency for Science, Technology and Research (A*STAR), aiming to discover new technologies and insights, apply them to the life sciences, and contribute to society at large.

Shigeo Murakami
President and Representative Director

Corporate profile

Company nameCerustar PTE. LTD
Address150 Kampong Ampat, #04-08 KA Centre, Singapore 368324
Telephone: +65 6334 8568
Date establishedJanuary 9, 2019
Scope of businessRegenerative medicine business
RepresentativeShigeo Murakami
CapitalSGD 650,080(as of June 1, 2023)